510(k) summary template
Build a US device summary outline anchored to 21 CFR 807.92. One free input set; complete evidence and professional review before submission.
What this is not: a clearance, approval, consent, signed record or submission. Responsible professional review is required. Jurisdiction: United States — FDA medical devices.
Structured information
Only de-identified, non-confidential information. No names, birth dates, contact details or patient record numbers. Examples are synthetic.
Provider: local deterministic template engine; no AI call or document upload. Inputs and drafts remain in this tab’s memory; reload clears them. Only the allowance and input hash are stored in your browser. Copy or download before leaving. Not a controlled clinical record system.
Build the supporting evidence
Copy or download your draft first. Signup opens the AnswerThis app and does not transfer this result.
How to use this workspace
- Choose the document and confirm its jurisdiction and institutional owner.
- Enter structured information or load the synthetic example, then confirm the de-identification attestation.
- Generate the outline and complete the unfinished prompts in the editor.
- Review the result with its responsible owner and export it into the controlled project workflow.
What to check
- Source edition and local applicability are distinct from the date of your document.
- Use only supported facts; a blank does not establish a negative finding.
- Keep identifiers, population, document versions and evidence consistent.
- Review drafts in the responsible institution’s controlled system before use.
Define the device and the summary scope
This workspace prepares a working outline for a US 510(k) summary with section anchors to 21 CFR 807.92. It is not a complete premarket notification and does not determine whether a device is eligible for the 510(k) pathway. Start with the device identity and the intended use that the responsible regulatory team has actually established. A draft summary cannot substitute for the underlying evidence package or a pathway assessment.
The form collects the organisation, product or study identifier, product title, document date and aggregate population context. Enter United States as the jurisdiction when using this US-specific structure. Selecting another jurisdiction does not translate the summary into that regulator’s requirements. The generated outline labels its US scope and leaves the device-specific sections open for completion. Contact details that a final submission may require should be entered later in the authorised system, not into this public form.
Keep trade, common and classification names distinct when completing the exported document. Similarly, distinguish the subject device from each cited predicate or reference device. A similar product name is not enough to establish that the comparison is appropriate. Preserve public device identifiers and dated evidence so reviewers can locate the exact records you used.
Build a comparison that the evidence can support
The outline separates device description, intended use, predicate identification and technological comparison. Complete these sections using controlled technical documents and the responsible team’s review. An intended-use difference or a technological difference may change the questions that the submission needs to address. The template does not decide whether a difference raises a new safety or effectiveness question, and it does not select or validate predicates.
Performance sections provide a place to summarise applicable nonclinical evidence and clinical evidence where relevant. Do not imply that a study was performed simply because a heading exists. Identify the actual tests, methods, acceptance criteria, results and limitations in the controlled dossier before writing a summary. Supporting reports may need specialist assessment that is outside the scope of this page. The generated text supplies no test results or substantial-equivalence conclusion.
Use the FDA source link to check the required content and the broader submission instructions at the time of preparation. The regulation anchor is a traceability aid, while the page’s section numbering is an authoring convenience. A grouped prompt is not a verbatim reproduction of the legal requirement. Reconcile the outline against the current official source and any device-specific guidance rather than assuming that completing every visible blank is sufficient.
Maintain a reviewable public-facing draft
Consider the relationship between the public summary and the supporting confidential submission materials. This workspace is for non-confidential, de-identified planning information only. It is not a secure dossier repository or a mechanism for determining what information can be withheld from public disclosure. Keep proprietary design details, personal contact information and sensitive source documents in the approved regulatory environment.
Review the exported summary for consistent names, identifiers, preparation date, intended use and comparisons. A reviewer should be able to trace each factual conclusion to the relevant evidence without guessing which device version was tested. Where evidence is incomplete, retain an explicit unfinished prompt and assign the work to the appropriate owner. Do not turn missing information into a favourable conclusion. Changes in the device or evidence may require substantive revision beyond the metadata entered here.
One successful input set is free on this page. Editing, copying and downloading that draft remain free, and the engine uses no AI provider. The Word-compatible export is an HTML document that can be opened in a word processor; it is not an FDA submission package or a native DOCX file. The draft warning stays attached. Only the responsible organisation can complete its review and submit through the applicable official process; this page issues no clearance or acknowledgement.
Sources, versions and jurisdiction
Jurisdiction: United States — FDA medical devices. Source review as of 2026-09-14. Source retrieval: 2026-09-13T22:50:11Z (editorial review, not a live document lookup). No agency endorsement. Original concise outlines with links; source documents remain the work of their respective owners. ICH materials © ICH; prompts are adapted summaries, not official templates.
- FDA, 21 CFR 807.92 — current regulation; verify on official page
Frequently asked questions
Is this a 510(k) summary or a 510(k) statement?
It is a working summary outline anchored to 21 CFR 807.92. It does not produce the alternative statement or determine which submission route is appropriate.
Does the tool validate my predicate device?
No. The predicate prompts require independently checked identification and comparison evidence. A similar product name is not proof of substantial equivalence.
What should I do with unfinished testing prompts?
Keep them visibly incomplete until the responsible team supplies reviewed evidence or documents why a category is inapplicable. The outline never infers that testing passed.
Does the source-review date fix the applicable regulation?
No. It records editorial review of the linked source. The link opens the current regulation; confirm the version applicable to the submission with its responsible owner.
Can I enter patient records or confidential information?
No. Use only de-identified, non-confidential information. Do not enter names, birth dates, contact details, record numbers, signed forms or source records. The tools do not de-identify records for you.
How many free runs are included?
This page includes one successful free input set per browser. Failed requests and re-exporting a result are free.
Does signup transfer my work or unlock more page runs?
Signup opens the AnswerThis app. It does not unlock more runs here or transfer your draft. Copy or download the result first.